Senators hold confirmation hearing for FDA commissioner nominee Heidi Overton
PBS · September 24, 2026Original source ↗
What happened
Heidi Overton, nominated for the position of FDA commissioner, was questioned by senators during her confirmation hearing. Overton's oversight would include the FDA's review of mifepristone, a medication used in abortions.
Why it matters
The outcome of this confirmation could impact regulatory decisions related to reproductive health medications.
How this story affects people
How does this story affect you if you are seeking an abortion or considering reproductive health options?
The confirmation of Heidi Overton as FDA commissioner could directly affect access to mifepristone, the leading abortion pill. If Overton's stance as an outspoken abortion critic influences regulatory decisions, it may result in stricter oversight or limitations on the availability of this medication.
Want this written about you?
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Get your RippleMore stories
- PoliticsResolution Foundation reports council tax disparities between London and other regions
- PoliticsDemocrats file lawsuit over federal agents at polling sites
- PoliticsSpeaker Johnson ends House session early for midterm campaigning
- PoliticsPeltola campaign responds to New York Times report on campaign operations